Core-shell nano-biomaterials for controlled oral delivery and pharmacodynamic activity of glibenclamide

International Journal of Biological Macromolecules

Volumn 70, Issue , 2014, Pages 20-25

  Maiti, Sabyasachi ^a   Mukherjee, Susweta ^a   Datta, Rana ^a  

^a GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

Author keywords

Controlled release; Critical association concentration; Dissolution efficiency; Glibenclamide; Hyperglycemia; Xanthan copolymer

Indexed keywords

ALLOXAN; COPOLYMER; GLIBENCLAMIDE; GLUCOSE; NANOCARRIER; WATER; XANTHAN; ANTIDIABETIC AGENT; BACTERIAL POLYSACCHARIDE; BIOMATERIAL; GLUCOSE BLOOD LEVEL; MICELLE; NANOCOMPOSITE; POLYMER;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CRITICAL ASSOCIATION CONCENTRATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; ETHERIFICATION; EVAPORATION; GLYCEMIC CONTROL; IN VITRO STUDY; MICELLIZATION; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; RABBIT; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; MICELLE; ORAL DRUG ADMINISTRATION; SOLUBILITY; SYNTHESIS;

ADMINISTRATION, ORAL; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD GLUCOSE; DRUG DELIVERY SYSTEMS; GLYBURIDE; HYPOGLYCEMIC AGENTS; MICELLES; NANOCOMPOSITES; PARTICLE SIZE; POLYMERS; POLYSACCHARIDES, BACTERIAL; RABBITS; SOLUBILITY;

EID: 84903836976     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.06.031     Document Type: Article

References (40)

1. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Adv. Drug Deliv. Rev. 2001, 46:3-26.
2. Thompson D., Chaubal M.V. Drug Deliv. Technol. 2000, 2:34-38.
3. Lipinski C.A. J. Pharmacol. Toxicol. Methods 2000, 44:235-249.
4. Hageluken A., Grunbaum L., Nurnberg B., Harhammer R., Schunack W., Seifert R. Biochem. Pharmacol. 1994, 47:1789-1795.
5. Davis S.N., Granner D.K. The Pharmacological Basis of Therapeutics 1996, 1487-1518. McGraw-Hill, New York. A.G. Gilman (Ed.).
6. Dixit R.P., Nagarsenker M.S. Indian J. Pharm. Sci. 2007, 69:370-377.
7. Sanghavi N.M., Venkastesh H., Tandel V. Drug Dev. Ind. Pharm. 1994, 20:1275-1283.
8. Obaidat A.A., Ababneh N.M. Jordan J. Pharm. Sci. 2009, 2:119-130.
9. Tashtoush B.M., Al-Qashi Z.Z., Najib N.M. Drug Dev. Ind. Pharm. 2004, 30:601-607.
10. Patel T.B., Patel L.D., Patel T.B., Makwana S.H., Patel T.R. Int. J. Pharm. Pharm. Sci. 2010, 2:138-141.
11. Singh J., Singh S. Drug Dev. Ind. Pharm. 1990, 16:2193-2198.
12. Savolainen J., Jarvinen K., Taipale H., Jaho P., Loftsson T., Jravinen T. Pharm. Res. 1998, 15:1696-1701.
13. Mudgal S.S., Jayaprakash S., Nagrajan M., Pancholi S.S. Int. J. Pharm. Res. 2010, 2:25-29.
14. Andrianov A.K., Payne L.G. Adv. Drug Deliv. Rev. 1998, 34:155-170.
15. Kwon G.S., Okano T. Adv. Drug Deliv. Rev. 1996, 21:107-116.
16. Kwon G.S. Adv. Drug Deliv. Rev. 2002, 54:167.
17. Miller D.W., Batrakova E.V., Waltner T.O., Yu A.V., Kabanov A.V. Bioconjugate Chem. 1997, 8:649-657.
18. Katayose S., Kataoka K. J. Pharm. Sci. 1998, 87:160-163.
19. Harada A., Kataoka K. Macromolecules 1996, 31:288-294.
20. Kim S.Y., Shin I.G., Lee Y.M., Cho C.G., Sung Y.K. J. Control. Release 1998, 51:13-22.
21. Ramaswamy M., Zhang X., Burt H.M., Wasan K.M. J. Pharm. Sci. 1997, 86:460-464.
22. Kabanov A., Batrakova E., Alakhov V. J. Control. Release 2002, 82:189-212.
23. Kabanov A.V., Alakhov V.Y. Crit. Rev. Ther. Drug Carrier Syst. 2002, 19:1-72.
24. Jiang G.B., Quan D., Liao K., Wang H. Mol. Pharm. 2006, 3:152-160.
25. Mekhail G.M., Kamel A.O., Awad G.A.S., Mortada N.D. Int. J. Biol. Macromol. 2012, 51:351-363.
26. Jeong Y.I., Kim D.H., Chung C.W., Yoo J.J., Choi K.H., Kim C.H., Ha S.H., Kang D.H. Int. J. Nanomed. 2011, 6:1415-1427.
27. Du Y.Z., Weng Q., Yuan H., Hu F.-Q. ACS Nano 2010, 4:6894-6902.
28. Krstonošić V., Dokić L., Milanović J. Food Hydrocolloids 2011, 25:361-367.
29. Katzbauer B. Properties and applications of xanthan gum. Polym. Degrad. Stab. 1998, 59:81-84.
30. Whistler R.L., BeMiller N. Carbohydrate Chemistry for Food Scientists 1997, Eagan Press, St Paul, MN. second ed.
31. Capron I., Brigandt G., Muller G. Polymer 1997, 38:5289-5295.
32. Domínguez A., Fernández A., González N., Iglesias E., Montenegro L. J. Chem. Educ. 1997, 74:1227-1231.
33. Korsmeyer R.W., Gurny R., Doelker E.M., Buri P., Peppas N.A. Int. J. Pharm. 1983, 15:25-35.
34. Maiti S., Ray S., Mandal B., Sarkar S., Sa B. J. Microencapsul. 2007, 24:743-756.
35. Kemp W. Organic Spectroscopy 1991, Macmillan Press Ltd., London, (Chapter 2). second ed.
36. Francis M.F., Cristea M., Yang Y., Winnik F.M. Pharm. Res. 2005, 22:209-219.
37. Lin H.R., Chang P.C. J. Biomed. Mater. Res. B: Appl. Biomater. 2013, 101:689-699.
38. Khan K.A. J. Pharm. Pharmacol. 1975, 28:48-49.
39. Abd Elbary A.A., Salem H.F., Maher M.E. Br. J. Pharmacol. Toxicol. 2011, 2:51-62.
40. Kahn C.R., Shechter Y. Goodman and Gilman's the Pharmacological Basis of Therapeutics 1991, 1484. McGraw-Hill, New York. W.R. Theodore, S.N. Alan, P. Taylor, A.G. Gilman (Eds.).